{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "1 Obstetrics and Gynecology, Morehouse School of Medicine, Atlanta, Georgia, USA",
    "BriaPro Therapeutics Corp., Philadelphia, PA, USA",
    "BriaCell Therapeutics Corp., Philadelphia, PA, USA",
    "University of Utah, Huntsman Cancer Institute (HCI), Salt Lake City, UT, USA"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 5,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Giuseppe Del Priore"
    },
    {
      "affs": [
        1
      ],
      "name": "Markus D Lacher"
    },
    {
      "affs": [
        2
      ],
      "name": "Miguel A Lopez-Lago"
    },
    {
      "affs": [
        2
      ],
      "name": "William V Williams"
    },
    {
      "affs": [
        3
      ],
      "name": "Suzanne Ostrand-Rosenberg"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/165ryv5kcae6g.bib",
  "cited_by": 0,
  "doi": "10.1136/jitc-2026-sitc2026.0404",
  "fulltext_url": null,
  "id": "165ryv5kcae6g",
  "issns": [
    "2051-1426"
  ],
  "landing_url": "https://doi.org/10.1136/jitc-2026-sitc2026.0404",
  "language": "en",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "lcc",
      "RC254-282"
    ],
    [
      "openalex",
      "2403|Immunotherapy and Immune Responses"
    ]
  ],
  "openalex": "W7225185577",
  "pdf_url": "https://jitc.bmj.com/content/14/Suppl_2/A450.full.pdf",
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-05",
  "publisher": "BMJ Publishing Group",
  "ris": "https://research.draconitic.com/paper/165ryv5kcae6g.ris",
  "sources": [
    {
      "first_seen": "2026-11-05T14:21:18Z",
      "native_id": "1a465972301444af821ae09bf452aaf7",
      "source": "doaj",
      "url": "https://doi.org/10.1136/jitc-2026-sitc2026.0404"
    }
  ],
  "subjects": [
    {
      "field": "biology",
      "origin": "openalex:2403|Immunotherapy and Immune Responses",
      "subfield": "immunology"
    }
  ],
  "title": "404 Development of BP-80, a soluble CD80 dimer (CD80-Fc) for cancer treatment",
  "title_text": "404 Development of BP-80, a soluble CD80 dimer (CD80-Fc) for cancer treatment",
  "type": "peer-reviewed",
  "updated_at": "2026-11-07T14:20:32Z",
  "url": "https://research.draconitic.com/paper/165ryv5kcae6g",
  "venue": "Journal for ImmunoTherapy of Cancer",
  "versions": []
}